De Novo Pharmaceuticals Investors

16 investors on Angel Roster list De Novo Pharmaceuticals in their portfolio. Most are venture capital firms and private equity firms and the largest groups are based in the United States, the United Kingdom and Singapore.

Investors are matched on the company name in their portfolio, so companies that share the name De Novo Pharmaceuticals can appear together.

Investors listed
16
With verified email
44%
Most common stage
Not specified
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 16 De Novo Pharmaceuticals investors

The most complete profiles first. Showing 16 of 16.

  • Eric BednarskiVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesWomen FoundedHR Tech

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Verified email available

  • Eric FritzVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesWomen FoundedHR Tech

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Verified email available

  • Kevin ChengVerified

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareWearablesWomen FoundedHR Tech

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Verified email available

  • Stephen ReedersVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesWomen FoundedHR Tech

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Verified email available

  • Stephen SmithVerified

    Venture Capital · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Verified email available

  • Akhilesh Pathipati

    Venture Capital · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Contact details available

  • Anand KumarVerified

    Venture Capital, Private Equity Firm, Micro VC · Singapore

    Health CareTelecommunicationsInvestment ManagementDesign

    Portfolio: Nujira, Velocix, De Novo Pharmaceuticals, Antenova and 3 more

    Verified email available

  • Anil DuaVerified

    Venture Capital, Private Equity Firm, Micro VC · United Arab Emirates

    Health CareTelecommunicationsDesignInfrastructure

    Portfolio: Nujira, Velocix, De Novo Pharmaceuticals, Antenova and 3 more

    Verified email available

  • Hugo Harrod

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareWearablesWomen FoundedHR Tech

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Contact details available

  • Jack Tanaka

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesWomen FoundedHR Tech

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Contact details available

  • Kyle Dempsey, MD, MBA

    Venture Capital, Private Equity Firm · United States

    Health CareWearablesWomen FoundedHR Tech

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Contact details available

  • Mary Shannon

    Venture Capital · United States

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Contact details available

  • Neil Akhurst

    Venture Capital, Private Equity Firm · United Kingdom

    Health CareWearablesWomen FoundedHR Tech

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Contact details available

  • Thomas Casdagli

    Venture Capital · United Kingdom

    Health CareWearablesWomen FoundedLife Science

    Portfolio: Vantia Therapeutics, Spherics, Onbone, Zipline Medical and 35 more

    Contact details available

  • V ShankarVerified

    Venture Capital, Private Equity Firm, Micro VC · Philippines

    Health CareTelecommunicationsDesignInfrastructure

    Portfolio: Nujira, Velocix, De Novo Pharmaceuticals, Antenova and 3 more

    Contact details available

  • Rahul Goswamy

    Venture Capital, Private Equity Firm, Micro VC · Singapore

    Health CareTelecommunicationsDesignInfrastructure

    Portfolio: Nujira, Velocix, De Novo Pharmaceuticals, Antenova and 3 more

    Contact details available

By location

Related industries

Most-backed portfolio companies

Frequently asked questions

How many De Novo Pharmaceuticals investors are on Angel Roster?

Angel Roster lists 16 De Novo Pharmaceuticals investors. 7 of them (44%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (16), Private Equity Firms (12) and Micro VC Firms (4). An investor can have more than one type, for example an angel who is also a venture partner.

Where are De Novo Pharmaceuticals investors based?

Most are based in the United States (8), the United Kingdom (4) and Singapore (2).

Which companies have De Novo Pharmaceuticals investors backed?

The most-backed portfolio companies among them are Tarsa Therapeutics (12), Vascular Pathways (12), Lombard Medical plc (12), Serentis (12) and Oxxon Therapeutics (12).

How do I contact De Novo Pharmaceuticals investors?

Create a free Angel Roster account to search and filter all 16, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.